JP2022534808A5 - - Google Patents

Info

Publication number
JP2022534808A5
JP2022534808A5 JP2021572542A JP2021572542A JP2022534808A5 JP 2022534808 A5 JP2022534808 A5 JP 2022534808A5 JP 2021572542 A JP2021572542 A JP 2021572542A JP 2021572542 A JP2021572542 A JP 2021572542A JP 2022534808 A5 JP2022534808 A5 JP 2022534808A5
Authority
JP
Japan
Prior art keywords
seq
chain variable
abpc
variable domain
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021572542A
Other languages
English (en)
Japanese (ja)
Other versions
JP7820153B2 (ja
JP2022534808A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/036435 external-priority patent/WO2020247827A1/en
Publication of JP2022534808A publication Critical patent/JP2022534808A/ja
Publication of JP2022534808A5 publication Critical patent/JP2022534808A5/ja
Application granted granted Critical
Publication of JP7820153B2 publication Critical patent/JP7820153B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021572542A 2019-06-06 2020-06-05 抗原結合タンパク質構築物およびその使用 Active JP7820153B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962858310P 2019-06-06 2019-06-06
US62/858,310 2019-06-06
US201962897965P 2019-09-09 2019-09-09
US62/897,965 2019-09-09
PCT/US2020/036435 WO2020247827A1 (en) 2019-06-06 2020-06-05 Antigen-binding protein constructs and uses thereof

Publications (3)

Publication Number Publication Date
JP2022534808A JP2022534808A (ja) 2022-08-03
JP2022534808A5 true JP2022534808A5 (cg-RX-API-DMAC7.html) 2023-06-13
JP7820153B2 JP7820153B2 (ja) 2026-02-25

Family

ID=71409480

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021572542A Active JP7820153B2 (ja) 2019-06-06 2020-06-05 抗原結合タンパク質構築物およびその使用

Country Status (7)

Country Link
US (1) US20220298260A1 (cg-RX-API-DMAC7.html)
EP (1) EP3980127A1 (cg-RX-API-DMAC7.html)
JP (1) JP7820153B2 (cg-RX-API-DMAC7.html)
CN (2) CN114786732A (cg-RX-API-DMAC7.html)
AU (1) AU2020287165A1 (cg-RX-API-DMAC7.html)
CA (1) CA3142735A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020247827A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL306129A (en) * 2021-04-07 2023-11-01 Mythic Therapeutics Inc Structures of antigen-binding proteins and antibodies and their uses
WO2024081729A2 (en) * 2022-10-12 2024-04-18 Mythic Therapeutics, Inc. Lrrc-15-binding protein constructs and uses thereof
WO2025252094A1 (zh) * 2024-06-05 2025-12-11 长春金赛药业有限责任公司 靶向叶酸受体α(FRα)的抗体、双特异性抗体和偶联物，及其制备和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7612181B2 (en) 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
CN102149825B (zh) 2008-07-08 2015-07-22 Abbvie公司 前列腺素e2双重可变结构域免疫球蛋白及其用途
WO2011028811A2 (en) 2009-09-01 2011-03-10 Abbott Laboratories Dual variable domain immunoglobulins and uses thereof
BR112012008833A2 (pt) 2009-10-15 2015-09-08 Abbott Lab imunoglobulinas de dominio variavel duplo e usos das mesmas
UY32979A (es) 2009-10-28 2011-02-28 Abbott Lab Inmunoglobulinas con dominio variable dual y usos de las mismas
TWI622402B (zh) * 2010-02-24 2018-05-01 免疫遺傳股份有限公司 葉酸受體１抗體類和免疫共軛物類及彼等之用途
JP5932670B2 (ja) * 2010-03-11 2016-06-08 ライナット ニューロサイエンス コーポレイション ｐＨ依存性の抗原結合を有する抗体
TWI667257B (zh) * 2010-03-30 2019-08-01 中外製藥股份有限公司 促進抗原消失之具有經修飾的ＦｃＲｎ親和力之抗體
EP3252072A3 (en) 2010-08-03 2018-03-14 AbbVie Inc. Dual variable domain immunoglobulins and uses thereof
BR112013025415B1 (pt) 2011-04-01 2021-03-16 Immunogen, Inc uso de um imunoconjugado antirreceptor de folato 1 (folr1)
EP2825553B1 (en) * 2012-03-14 2018-07-25 Regeneron Pharmaceuticals, Inc. Multispecific antigen-binding molecules and uses thereof
CN113150145B (zh) * 2013-08-30 2025-02-14 伊缪诺金公司 用于检测叶酸受体1的抗体和测定

Similar Documents

Publication Publication Date Title
JP7607498B2 (ja) 成長分化因子１５（ｇｄｆ－１５）に対するモノクローナル抗体およびがん悪液質およびがんを処置するためのその使用
CN102741282B (zh) 针对转铁蛋白受体的抗体以及其用于依赖于铁的肿瘤的免疫疗法的用途
CN112771161A (zh) 滋养层细胞表面抗原2(trop2)特异性抗体
JP2022543771A5 (cg-RX-API-DMAC7.html)
JP2022514693A (ja) Ｍｕｃ１８に特異的な抗体
JP2022512862A (ja) ＴＧＦ－β受容体融合タンパク質医薬組成物およびその使用
CN109195991A (zh) 对糖基化pd-l1特异的双重功能抗体及其使用方法
JP2026050358A (ja) 治療用抗ｃｄ４０リガンド抗体
JP2024119785A (ja) 葉酸受容体アルファに特異的な抗体
JP2022527151A5 (cg-RX-API-DMAC7.html)
JP6640232B2 (ja) クロストリジウム・ディフィシル感染症の治療のための、クロストリジウム・ディフィシルのトキシンａ及びトキシンｂに対する四重特異性の八量体型結合剤及び抗体
JP2022535452A5 (cg-RX-API-DMAC7.html)
CN108025093A (zh) 用于在治疗癌症中使用的放射性标记的抗体片段
JP2022534808A5 (cg-RX-API-DMAC7.html)
JP2022514786A (ja) Ｍｕｃ１８に特異的な抗体
JP2023544143A5 (cg-RX-API-DMAC7.html)
TW202302651A (zh) 一種雙抗組合及其應用
JP2022521305A (ja) 抗ｐｄ－ｌ１抗体及びその使用
CN111848805B (zh) 用于肿瘤免疫治疗的具有双Her2位点的双特异性抗体
JP2018525347A (ja) 癌免疫療法に使用するための二重特異性抗体
KR20140090295A (ko) T 세포 특이적인 인간화 단일조각항체 전달체
JP2021516670A (ja) 抗ｔｒａｉｌｒ２抗体−毒素−複合体およびその抗腫瘍治療における薬物用途
TW202207993A (zh) 位點特異性her2抗體-藥物共軛物之治療
CN103417965B (zh) 一种含有抗vegf抗体的药物组合物
JP2022551844A5 (cg-RX-API-DMAC7.html)